US Broker Ratings

iRadimed Corporation (IRMD) Stock Analysis: Evaluating the Growth Potential in MRI-Compatible Medical Devices

iRadimed Corporation (NASDAQ: IRMD), a prominent player in the healthcare sector, specializes in creating innovative medical devices compatible with magnetic resonance imaging (MRI). With a market cap of $1.26 billion,..

STAAR Surgical Company (STAA) Stock Analysis: Insights into the 23.34% Potential Upside

STAAR Surgical Company (NASDAQ: STAA) is an intriguing player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $934.99 million, STAAR Surgical..

Oculis Holding AG (OCS) Stock Analysis: A Biotech Gem with 63.59% Potential Upside

Investors eyeing the biotechnology sector may want to pay close attention to Oculis Holding AG (OCS), a Swiss company making significant strides in ophthalmic disease treatments. With a market capitalization..

Syndax Pharmaceuticals, Inc. (SNDX) Stock Analysis: A 90.91% Potential Upside Sparks Investor Interest

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a biotechnology company based in New York and focused on innovative cancer therapies, is drawing significant attention from the investor community. With a robust market..

Day One Biopharmaceuticals (DAWN) Investor Outlook: Unveiling a Potential 111% Upside

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) is making waves in the biotechnology sector with its innovative approach to treating both childhood and adult diseases. As a commercial-stage company, Day One..

Nutex Health Inc. (NUTX) Stock Analysis: An Astonishing 68% Potential Upside Awaits Investors

Nutex Health Inc. (NUTX) is making waves in the healthcare sector with a remarkable potential upside of 68.32%, according to analyst target prices. With a current market cap of $1.05..

Immatics N.V. (IMTX) Stock Analysis: Exploring the 103.89% Potential Upside in the Biotechnology Sector

Immatics N.V. (NASDAQ: IMTX), a trailblazer in the biotechnology sector, is capturing the attention of investors with its innovative approach to cancer treatment and a significant potential upside. As a..

Savara, Inc. (SVRA) Investor Outlook: Analyst Ratings Signal a Potential 93.77% Upside

Savara Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, has recently caught the attention of investors and analysts alike. With its market cap standing at $1.14..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: Unlocking a Potential 78.81% Upside in the Biotech Sector

ArriVent BioPharma, Inc. (NASDAQ: AVBP) is emerging as a noteworthy player in the biotechnology sector with a market capitalization of $928.83 million. This clinical-stage biopharmaceutical company is focused on developing..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Navigating Growth with a 7.80% Potential Upside

Phibro Animal Health Corporation (NASDAQ: PAHC), a prominent entity in the healthcare sector, has carved a niche in the drug manufacturing industry, focusing on specialty and generic animal health products...

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Biotech Visionary with a 205% Potential Upside

As investors search for promising opportunities in the healthcare sector, LENZ Therapeutics, Inc. (NASDAQ: LENZ) emerges as a compelling prospect. Specializing in biopharmaceutical solutions aimed at improving vision, LENZ Therapeutics..

CureVac N.V. (CVAC): Investor Outlook on the German mRNA Innovator Amidst Acquisition by BioNTech

CureVac N.V. (NASDAQ: CVAC), a pioneering biopharmaceutical company based in Tübingen, Germany, has long captured investor interest with its focus on messenger ribonucleic acid (mRNA) technology. With a market capitalization..

Cronos Group Inc. (CRON) Stock Analysis: Navigating a 6.1% Revenue Growth in a Challenging Market

Cronos Group Inc. (CRON), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, stands at an intriguing crossroad for investors. With a market..

Zymeworks Inc. (ZYME): Investor Outlook on a Promising Biotech with 59% Upside Potential

Zymeworks Inc. (NASDAQ: ZYME), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to developing biotherapeutics for cancer and autoimmune diseases. With a market..

InMode Ltd. (INMD) Stock Analysis: A Look at Financial Health and Market Positioning

For investors eyeing the dynamic field of minimally invasive medical aesthetics, InMode Ltd. (NASDAQ: INMD) presents a compelling opportunity. Based in Yokne’am, Israel, this healthcare sector player operates within the..

CareDx, Inc. (CDNA) Stock Analysis: Exploring Growth Potential with a 5.77% Upside

CareDx, Inc. (NASDAQ: CDNA), a prominent player in the healthcare sector specializing in diagnostics and research, is gaining significant attention from investors. With a market capitalization of $1.11 billion, CareDx..

DoubleVerify Holdings, Inc. (DV) Stock Analysis: Exploring a 25.60% Potential Upside

DoubleVerify Holdings, Inc. (NASDAQ: DV) is making waves in the advertising industry, leveraging technology to redefine how brands measure and enhance their digital media investments. With a market capitalization of..

Paylocity Holding Corporation (PCTY) Stock Analysis: Exploring a 36.61% Potential Upside for Savvy Investors

Paylocity Holding Corporation (NASDAQ: PCTY), a prominent player in the technology sector, operates within the niche of cloud-based human capital management and payroll software solutions. With a market capitalization of..

PAR Technology Corporation (PAR) Stock Analysis: Exploring a 107% Potential Upside

PAR Technology Corporation (NYSE: PAR) is a name that has been capturing the attention of investors with its promising potential upside and innovative offerings in the software application industry. With..

Cadence Design Systems, Inc. (CDNS): Analyst Consensus and Growth Potential in the Booming Technology Sector

Cadence Design Systems, Inc. (NASDAQ: CDNS), a stalwart in the technology sector, specifically within the software application industry, is drawing attention with its impressive market capitalization of $87.33 billion. Headquartered..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds